Warning: Undefined array key "network" in /hshare1/ZETTAI_path_WA_slash_usr_slash_proj_KARA/usr/proj/tcng/htdocs/tcng.php on line 565
Edge
PSAT1 → EIF4EBP1
Networks Including this Edge
| GSE23553_top8000 - GSE23553 - SiGN-BN NNSR | Gene expression changes with induction of in-vitro platinum-resistance in ovarian cancer cell lines. |
| GSE32474_top8000 - GSE32474 - SiGN-BN NNSR | Comparison between cell lines from 9 different cancer tissue (NCI-60) (Affymetrix U133 Plus 2.0) |
| GSE10245_egf1520 - GSE10245 - SiGN-BN HC+Bootstrap | Gene expression differences between adenocarcinoma and squamous cell carcinoma in human NSCLC |
| GSE10843_egf1520 - GSE10843 - SiGN-BN HC+Bootstrap | mRNA Cancer Cell Line Profiles |
| GSE10972_egf1520 - GSE10972 - SiGN-BN HC+Bootstrap | Colon cancer |
| GSE12276_egf1520 - GSE12276 - SiGN-BN HC+Bootstrap | Expression data from primary breast tumors |
| GSE13067_egf1520 - GSE13067 - SiGN-BN HC+Bootstrap | Expression data from primary colorectal cancers |
| GSE13591_egf1520 - GSE13591 - SiGN-BN HC+Bootstrap | Integrated genomics approach to detect allelic imbalances in multiple myeloma |
| GSE13598_egf1520 - GSE13598 - SiGN-BN HC+Bootstrap | mRNA expression of 131 cancer cell lines |
| GSE14333_egf1520 - GSE14333 - SiGN-BN HC+Bootstrap | Expression data from 290 primary colorectal cancers |
| GSE15212_egf1520 - GSE15212 - SiGN-BN HC+Bootstrap | Identification and validation of NOL5A and RPS2 as potential therapeutic targtes in colorectal cancer |
| GSE15471_egf1520 - GSE15471 - SiGN-BN HC+Bootstrap | Whole-Tissue Gene Expression Study of Pancreatic Ductal Adenocarcinoma |
| GSE17372_egf1520 - GSE17372 - SiGN-BN HC+Bootstrap | Molecular Classification of AIDS-Related Lymphomas [including third-party data] |
| GSE18105_egf1520 - GSE18105 - SiGN-BN HC+Bootstrap | Stage II and stage III colorectal cancer |
| GSE18842_egf1520 - GSE18842 - SiGN-BN HC+Bootstrap | Gene expression analysis of human lung cancer and control samples |
| GSE19188_egf1520 - GSE19188 - SiGN-BN HC+Bootstrap | Expression data for early stage NSCLC |
| GSE19615_egf1520 - GSE19615 - SiGN-BN HC+Bootstrap | Integrated genomic and function characterization of the 8q22 gain |
| GSE19804_egf1520 - GSE19804 - SiGN-BN HC+Bootstrap | Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan |
| GSE20685_egf1520 - GSE20685 - SiGN-BN HC+Bootstrap | Microarray-based molecular subtyping of breast cancer |
| GSE20916_egf1520 - GSE20916 - SiGN-BN HC+Bootstrap | Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data |
| GSE21501_egf1520 - GSE21501 - SiGN-BN HC+Bootstrap | A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma |
| GSE21510_egf1520 - GSE21510 - SiGN-BN HC+Bootstrap | Clinical Significance of Osteoprotegerin Expression in Human Colorectal Cancer |
| GSE23120_egf1520 - GSE23120 - SiGN-BN HC+Bootstrap | Basal gene expression data from Human Variation Panel |
| GSE23553_egf1520 - GSE23553 - SiGN-BN HC+Bootstrap | Gene expression changes with induction of in-vitro platinum-resistance in ovarian cancer cell lines. |
| GSE23991_egf1520 - GSE23991 - SiGN-BN HC+Bootstrap | Effect of zebularine on primary human liver cancer cell lines |
| GSE25055_egf1520 - GSE25055 - SiGN-BN HC+Bootstrap | Discovery cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| GSE29288_egf1520 - GSE29288 - SiGN-BN HC+Bootstrap | Comparison between cell lines from 9 different cancer tissue (NCI-60) (Agilent WG platform) |
| GSE32474_egf1520 - GSE32474 - SiGN-BN HC+Bootstrap | Comparison between cell lines from 9 different cancer tissue (NCI-60) (Affymetrix U133 Plus 2.0) |
| GSE4183_egf1520 - GSE4183 - SiGN-BN HC+Bootstrap | Inflammation, adenoma and cancer: objective classification of colon biopsy specimens with gene expression signature |
| GSE4581_egf1520 - GSE4581 - SiGN-BN HC+Bootstrap | Gene Expression Profiles of Multiple Myeloma (N=414) Before Treatment |
| GSE5846_egf1520 - GSE5846 - SiGN-BN HC+Bootstrap | NCI-60 Cancer Cell Line |
| GSE6401_egf1520 - GSE6401 - SiGN-BN HC+Bootstrap | Up-regulation of translational machinery and distinct genetic subgroups characterize hyperdiploidy in multiple myeloma |
| GSE6465_egf1520 - GSE6465 - SiGN-BN HC+Bootstrap | Expression data of Hepatocellular Carcinoma |
| GSE6477_egf1520 - GSE6477 - SiGN-BN HC+Bootstrap | Expression data from different stages of plasma cell neoplasm |
| GSE7390_egf1520 - GSE7390 - SiGN-BN HC+Bootstrap | Strong Time Dependence of the 76-Gene Prognostic Signature |
| GSE8332_egf1520 - GSE8332 - SiGN-BN HC+Bootstrap | Death receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL |
| GSE9348_egf1520 - GSE9348 - SiGN-BN HC+Bootstrap | Expression data from healthy controls and early stage CRC patient's tumor |
